We are live on ! Find out more
CNTB

Connect Biopharma Holdings
CNTB

12 hedge funds and large institutions have $6.87M invested in Connect Biopharma Holdings in 2024 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 4 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

5.76% less ownership

Funds ownership: 12.93% → 7.17% (-5.8%)

18% less capital invested

Capital invested by funds: $8.4M → $6.87M (-$1.53M)

20% less funds holding

Funds holding: 15 → 12 (-3)

60% less first-time investments, than exits

New positions opened: 2 | Existing positions closed: 5

75% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 4

Holders
12
Holders Change
-3
Holders Change %
-20%
% of All Funds
0.17%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
4
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Commonwealth Equity Services
Commonwealth Equity Services
Massachusetts
+$24.3K
2
KMWM
Keudell/Morrison Wealth Management
Oregon
+$10.3K
3
Simplex Trading
Simplex Trading
Illinois
+$98

Top Sellers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
-$3.61M
2
Renaissance Technologies
Renaissance Technologies
New York
-$70.6K
3
UOC
UBS O'Connor
Illinois
-$61.4K
4
XT
XTX Topco
Cayman Islands
-$18.3K
5
TSS
Two Sigma Securities
New York
-$14.5K
Name Holding Trade Value Shares
Change 		Change in
Stake
BCM
1
BML Capital Management
Indiana
$3.59M -$122 -100 -0%
BlackRock
2
BlackRock
New York
$1.81M – – –
UOC
3
UBS O'Connor
Illinois
$889K -$61.4K -50,490 -9%
Renaissance Technologies
4
Renaissance Technologies
New York
$417K -$70.6K -58,100 -19%
Geode Capital Management
5
Geode Capital Management
Massachusetts
$48.7K – – –
Commonwealth Equity Services
6
Commonwealth Equity Services
Massachusetts
$35K +$24.3K +20,000 New
KMWM
7
Keudell/Morrison Wealth Management
Oregon
$34.3K +$10.3K +8,500 +76%
RhumbLine Advisers
8
RhumbLine Advisers
Massachusetts
$28.7K – – –
Two Sigma Investments
9
Two Sigma Investments
New York
$18.8K -$729 -600 -5%
JP Morgan Chase
10
JP Morgan Chase
New York
$211 – – –
Qube Research & Technologies (QRT)
11
Qube Research & Technologies (QRT)
United Kingdom
$80 – – –
RCM
12
RA Capital Management
Massachusetts
– -$3.61M -3,062,871 Closed
XT
13
XTX Topco
Cayman Islands
– -$18.3K -15,506 Closed
TSS
14
Two Sigma Securities
New York
– -$14.5K -12,307 Closed
Royal Bank of Canada
15
Royal Bank of Canada
Ontario, Canada
– -$1K -449 Closed
Fidelity Investments
16
Fidelity Investments
Massachusetts
– -$28 -23 Closed
Simplex Trading
17
Simplex Trading
Illinois
– +$98 +81 New

CNTB Hedge Fund Activity: Q1 2024 in Review

12 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Connect Biopharma Holdings (CNTB) for Q1 2024, worth a combined $6.87M — down 18% from $8.4M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of CNTB and 2 opened new positions — a net loss of 3 holders — while 4 trimmed existing stakes and 1 added.

The largest buyer was Commonwealth Equity Services, opening a new position worth an estimated $24.3K. The largest seller was RA Capital Management, exiting entirely with an estimated $3.61M sold.

  • 12 institutional investors held Connect Biopharma Holdings (CNTB) as of Q1 2024, down from 15 in Q4 2023.
  • Funds reported $6.87M of Connect Biopharma Holdings stock for Q1 2024, down 18% quarter-over-quarter.
  • 2 funds opened new Connect Biopharma Holdings positions in Q1 2024 and 5 closed out, a net change of -3 holders.
  • The largest Connect Biopharma Holdings buyer in Q1 2024 was Commonwealth Equity Services, an estimated $24.3K added.
  • The largest Connect Biopharma Holdings seller in Q1 2024 was RA Capital Management, an estimated $3.61M sold.

Based on aggregated 13F filings for Q1 2024.